Emile Voest

Emile Voest

Just one WGS test is enough to reveal everything you need to know to provide a patient with metastatic cancer with targeted treatment, be it a registered therapy or part of a research trial.

Back to news

More news

New study using Hartwig Medical Foundation data maps how breast cancer’s genetic makeup shifts when it spreads

New study using Hartwig Medical Foundation data maps how breast cancer’s genetic makeup shifts when it spreads

16-07-2026

Analysis of nearly 1,300 tumor genomes across ten genomic subtypes points to candidate drug targets and biomarkers for metastatic breast …

Whole genome sequencing to improve individual cancer treatment in Finland

Whole genome sequencing to improve individual cancer treatment in Finland

10-07-2020

Since August 2019, Docrates, a private cancer center in Finland, uses the whole genome sequencing test from Hartwig Medical Foundation to …

In the media: Rarity – Personalised cancer treatment – fact not fiction

In the media: Rarity – Personalised cancer treatment – fact not fiction

28-02-2022

Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl